Eichen Dawn M, Mestre Zoe L, Strong David R, Rhee Kyung E, Boutelle Kerri N
Department of Pediatrics, University of California San Diego, San Diego, California.
Joint Doctoral Program in Clinical Psychology, SDSU/UC San Diego, San Diego, California.
Pediatr Obes. 2020 Jun;15(6):e12621. doi: 10.1111/ijpo.12621. Epub 2020 Feb 25.
Early weight loss (rapid response [RR]) is associated with better outcomes in adults. Less is known about RR in children enrolled in weight-loss treatment. The aim of the current study was to establish an RR weight-loss threshold following 4 weeks of pediatric obesity treatment and identify characteristics associated with achieving RR. One hundred thirty-seven children aged 8 to 12 with overweight/obesity and parents participated in 6 months of family-based or parent-based treatment. Receiver operating characteristic curves evaluated how weight loss at week 4 related to decreases of 5% at posttreatment and 10% at 6- and 18-month follow-ups of standardized body mass index (BMIz), percentage distance of a child's BMI from the median BMI for sex and age, and percentage above the 95th percentile. Weight loss of 2.4% to 3.4% at week 4 predicted 5% change at posttreatment (AUC's = .68-.75; P's ≤ .002) and 10% change at 6-month follow-up (AUC's = .63-.70; P's ≤ .02). No model was significant at 18-month follow-up. Amount of parent weight (lbs) change at week 4 was associated with child achieving RR. Males and Non-Hispanic Whites were more likely to achieve RR. This threshold could be used to mark early significant progress and guide clinical evaluations of treatment response to paediatric obesity treatment.
早期体重减轻(快速反应[RR])与成人更好的治疗结果相关。对于接受减肥治疗的儿童中的RR情况,人们了解较少。本研究的目的是确定小儿肥胖治疗4周后的RR体重减轻阈值,并确定与实现RR相关的特征。137名8至12岁超重/肥胖儿童及其父母参与了为期6个月的家庭式或家长式治疗。受试者工作特征曲线评估了第4周时的体重减轻与治疗后标准化体重指数(BMIz)下降5%、6个月和18个月随访时下降10%之间的关系,以及儿童BMI与性别和年龄中位数BMI的百分比距离,以及高于第95百分位数的百分比。第4周体重减轻2.4%至3.4%可预测治疗后变化5%(曲线下面积[AUC]=0.68 - 0.75;P值≤0.002)以及6个月随访时变化10%(AUC=0.63 - 0.70;P值≤0.02)。在18个月随访时没有模型具有显著性。第4周时父母体重(磅)的变化量与儿童实现RR相关。男性和非西班牙裔白人更有可能实现RR。这个阈值可用于标记早期的显著进展,并指导对小儿肥胖治疗反应的临床评估。